11 completed, 1 not yet recruiting. 6 Phase 2, 3 Phase 4, 2 Phase 1, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 6 |
| Phase 4 | 3 | Completed 2, Not yet recruiting 1 |
| Phase 1 | 2 | Completed 2 |
| Phase 3 | 2 | Completed 2 |
Follow Vaxigrip®: new trials by email Literature Review of Vaxigrip® trials Research Report on Vaxigrip®
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase IV Clinical Trial of Influenza Vaccine (Split Virion), Inactivatedin (Anflu®) Pregnant Women (AnFLU-PREG) Anflu®, Vaxigrip® - Influenza | Phase 4 | Not yet recruiting | Sinovac Biotech Co., Ltd | 150 | 2026-10-01 | 2026-09-21 |
| Safety and Immunogenicity of a Vi-DT Typhoid Conjugate Vaccine Vi-DT, Typhim Vi®, VAXIGRIP® - Typhoid | Phase 1 | Completed | International Vaccine Institute | 144 | 2016-05-19 | 2020-04-28 |
| The Immune Response to Influenza Vaccinations in Elderly Individuals Vaxigrip® - Influenza | Phase 4 | Completed | National University Hospital, Singapore | 240 | 2013-12-01 | 2017-08-30 |
| Routes of Immunization and Flu Immune Responses INTANZA® 15, Vaxigrip®, INTANZA® 15 T - Influenza | Phase 1 / Phase 2 | Completed | Assistance Publique - Hôpitaux de Paris | 60 | 2012-10-01 | 2013-08-05 |
| Study of Sanofi Pasteur's Intradermal Influenza Vaccine (IDflu™) in Adults and Elderly in Korea IDflu™: Split virion inactivated influenza vaccine, Vaxigrip®: Split virion inactivated influenza vaccine - Influenza | Phase 4 | Completed | Sanofi Pasteur, a Sanofi Company | 240 | 2010-10-01 | 2018-09-13 |
| Study of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Subjects in Singapore CYD Dengue vaccine, NaCl + influenza virus or hepatitis A vaccine - Dengue Fever, Dengue Hemorrhagic Fever | Phase 2 | Completed | Sanofi Pasteur, a Sanofi Company | 1198 | 2009-04-07 | 2022-03-21 |
| Influenza Vaccine Dose-Response in Infants and Toddlers: Immunogenicity and Reactogenicity Inactivated Influenza Vaccine Trivalent Types A and B (Split Virion) - Influenza | Phase 3 | Completed | British Columbia Centre for Disease Control | 262 | 2008-08-01 | 2011-08-04 |
| Immunogenicity of the Inactivated Split-Virion Influenza Vaccine in Renal Transplant Subjects Inactivated, split-virion influenza virus - Influenza, Orthomyxoviridae Infections | Phase 2 | Completed | Sanofi Pasteur, a Sanofi Company | 62 | 2007-11-01 | 2014-01-14 |
| Study of Immune Response in Adults and Elderly Subjects Vaccinated With Inactivated Influenza Vaccines Inactivated, split-virion, influenza vaccine, Inactivated, split-virion influenza vaccine - Influenza, Orthomyxovirus Infections | Phase 2 | Completed | Sanofi Pasteur, a Sanofi Company | 160 | 2007-09-01 | 2015-06-17 |
| Study of Inactivated, Split-Virion Influenza Vaccine Compared With the Reference Vaccine Vaxigrip® in the Elderly Inactivated, split-virion influenza vaccine - Orthomyxoviridae Infection, Influenza | Phase 3 | Completed | Sanofi Pasteur, a Sanofi Company | 3707 | 2006-09-01 | 2014-01-14 |
| Immunogenicity Study of the Influenza Vaccine in Adults Inactivated, split-virion influenza vaccine, Inactivated, split-virion, influenza virus - Orthomyxoviridae Infections, Influenza | Phase 2 | Completed | Sanofi Pasteur, a Sanofi Company | 978 | 2005-09-01 | 2014-01-14 |
| Study of Inactivated, Split-Virion Influenza Vaccine Administered by Intradermal Route Versus Vaxigrip® in Adults Inactivated, split-virion influenza vaccine - Influenza, Orthomyxoviridae Infection | Phase 2 | Completed | Sanofi Pasteur, a Sanofi Company | 1150 | 2003-09-01 | 2014-01-13 |
Influenza, Human (10) · Orthomyxoviridae Infections (6) · Dengue (1) · Frailty (1) · Respiratory Tract Infections (1) · Severe Dengue (1) · Typhoid Fever (1)
Sanofi Pasteur, a Sanofi Company (7) · Assistance Publique - Hôpitaux de Paris (1) · British Columbia Centre for Disease Control (1) · International Vaccine Institute (1) · National University Hospital, Singapore (1) · Sinovac Biotech Co., Ltd (1)
France (4) · Belgium (3) · Lithuania (2) · Singapore (2) · Canada (1) · China (1) · Czechia (1) · Germany (1) · Italy (1) · South Korea (1) · Switzerland (1)
Danuta M Skowronski, MD (1) · Maria Rosario Capeding, MD (1) · Professor Paul Anantharajah Tambyah, MD (1) · Qi Hongbo (1)
PMID 19261173, PMID 19341446, PMID 21768314, PMID 21857263, PMID 22894958, PMID 23778938, PMID 23839107, PMID 25483667, PMID 29776750, PMID 30455722, PMID 30843873
2014 (1)